What changes in your 50s

The 50s combine continued slow decline with several discrete events:

Women: menopause arrives

Median age of menopause is 51, with normal range 45-55. After the final period, hormones stabilize at low levels:

Men in their 50s

Average total testosterone in the late 50s is about 400 ng/dL, well below optimal for most men's symptom thresholds. Many men in their 50s are appropriate candidates for TRT. The TRT decision in the 50s involves:

The men in their 50s who do well on TRT are those who pair it with resistance training, adequate protein, sleep, and ongoing monitoring.

Bone density attention

Both sexes lose bone density in the 50s, women dramatically, men gradually. This is the decade to:

Cardiovascular focus

The 50s is when cardiovascular risk profiles diverge sharply. Critical labs:

Muscle preservation

Sarcopenia, age-related muscle loss, accelerates in the 50s without active intervention. The countermeasures:

Labs to monitor

Comprehensive panels every 6 months in the 50s. Same baseline as before plus:

The principle: The 50s are when active replacement becomes the right call for many. Watching and waiting through this decade often means losing ground that's hard to recover later. Smart, lab-driven intervention preserves what would otherwise decline.

Bottom line

The 50s are the decade where intervention shifts from optimization to active replacement. Women face the menopause transition and HRT's window of opportunity. Men face increasingly clear hypogonadism. Both face accelerating bone, muscle, and cardiovascular changes. Smart, lab-driven hormone replacement, training, nutrition, and ongoing monitoring define how the next 30 years unfold.

~51
median age of menopause
~400
ng/dL, average male T in late 50s
2-3%
annual bone density loss in early postmenopause